The Emergence of the Metabolic Syndrome with Menopause
The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Abstract
Women with the metabolic syndrome (central obesity, insulin resistance, and dyslipidemia) are known to be at especially high risk for cardiovascular disease (CVD). The prevalence of the metabolic syndrome increases with menopause and may partially explain the apparent acceleration in CVD after menopause. The transition from pre- to postmenopause is associated with the emergence of many features of the metabolic syndrome, including 1) increased central (intraabdominal) body fat; 2) a shift toward a more atherogenic lipid profile, with increased low density lipoprotein and triglycerides levels, reduced high density lipoprotein, and small, dense low density lipoprotein particles; 3) and increased glucose and insulin levels. The emergence of these risk factors may be a direct result of ovarian failure or, alternatively, an indirect result of the metabolic consequences of central fat redistribution with estrogen deficiency. It is unclear whether the transition to menopause increases CVD risk in all women or only those who develop features of the metabolic syndrome. This article will review the features of the metabolic syndrome that emerge with estrogen deficiency. A better understanding of these metabolic changes with menopause will aid in the recognition and treatment of women at risk for future CVD, leading to appropriate interventions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Disturbances of this metabolic signal lead to the development of metabolic syndrome and a higher cardiovascular risk in women.”
From Estrogen deficiency and the origin of obesity during menopause (2014) · cites this paper as [31]
Citations
Cites
3 retracted
Changes in energy balance and body composition at menopause: a controlled longitudinal study.
Poehlman, E. T., Toth, M. J., & Gardner, A. W. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-9-199511010-00005 · Cited by 520 · cited 4×
“Several groups have shown increased fasting insulin (22, 48) and increased fasting glucose levels (37, 63) in postmenopausal compared with premenopausal women, which would imply worsened insulin resistance with the menopause.”
BackgroundInfluentialRetractedMenopause, energy expenditure, and body composition
Poehlman, E. T. (2002) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2002.810705.x · Cited by 137 · cited 1×
“Menopause is also associated with reduced lean body mass (muscle) and this appears to be related to decreased physical activity (36).”
BackgroundRetractedPoehlman, É. T., Toth, M., Ades, P. A., & Rosen, C. J. (1997) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1997.1160662.x · Cited by 128 · cited 4×
“sociated with weight gain, most studies do not reveal increases in BMI independent of normal aging (23, 24).”
BackgroundInfluentialRetractedGrundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154 · cited 1×
“Although syndrome X was initially coined by Gerald Reaven in 1988 (16), the features of the metabolic syndrome were first described by Vague (17) and have subsequently been called the insulin resistance syndrome, the central obesity syndrome, and the deadly quartet.”
BackgroundThe metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033 · cited 1×
“The metabolic syndrome may not be a single disease entity, but, rather, a constellation of closely related risk factors that together convey substantially increased cardiovascular risk after accounting for traditional CVD risk factors (12).”
BackgroundPark, Y.-W., Zhu, S., Palaniappan, L., Heshka, S., Carnethon, M. R., & Heymsfield, S. B. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.4.427 · Cited by 2,074 · cited 3×
“The metabolic syndrome is estimated to affect approximately 20–30% of the middle-aged population (10), and prevalence appears to be increasing in the U.”
BackgroundInfluentialChambless, L. E., Heiss, G., Folsom, A. R., Rosamond, W., Szklo, M., Sharrett, A. R., & Clegg, L. X. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009302 · Cited by 1,990
Thompson, S. G., Kienast, J., Pyke, S. D. M., Haverkate, F., & van de Loo, J. C. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321003 · Cited by 1,821
Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction
Austin, M. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410130125037 · Cited by 1,780 · cited 2×
“The risk of CVD is 3-fold higher in women with small, dense LDL than in those with large, buoyant LDL (45).”
BackgroundHokanson, J. E., & Austin, M. A. (1996) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199604000-00014 · Cited by 1,706
Lapidus, L., Bengtsson, C., Larsson, B., Pennert, K., Rybo, E., & Sjöström, L. (1984) · BMJ · doi:10.1136/bmj.289.6454.1257 · Cited by 1,660 · cited 1×
“Women with high amounts of visceral fat have an excess of cardiovascular mortality and associated metabolic abnormalities (31).”
BackgroundRidker, P. M., Buring, J. E., Shih, J., Matias, M., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.98.8.731 · Cited by 1,642 · cited 1×
“CRP is a marker of the presence and intensity of subclinical inflammation that independently predicts CVD risk in men and women (74).”
BackgroundAssociations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
Harris, T. B., Ferrucci, L., Tracy, R. P., Corti, M. C., Wacholder, S., Ettinger, W. H., Heimovitz, H., Cohen, H. J., & Wallace, R. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00066-2 · Cited by 1,488
Krotkiewski, M., Björntorp, P., Sjöström, L., & Smith, U. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111040 · Cited by 1,456 · cited 1×
“Estrogen promotes the accumulation of gluteo-femoral fat (21), and the loss of estrogen with menopause is associated with an increase in central fat (22).”
BackgroundThe Degree of Masculine Differentiation of Obesities
VAGUE, J. (1956) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/4.1.20 · Cited by 1,410
Menopause and Risk of Cardiovascular Disease: The Framingham Study
KANNEL, W. B., HJORTLAND, M. C., McNAMARA, P. M., & GORDON, T. (1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-85-4-447 · Cited by 1,395
(1991) · Archives of Internal Medicine · doi:10.1001/archinte.151.6.1071 · Cited by 1,137
Menopause and Risk Factors for Coronary Heart Disease
Matthews, K. A., Meilahn, E., Kuller, L. H., Kelsey, S. F., Caggiula, A. W., & Wing, R. R. (1989) · New England Journal of Medicine · doi:10.1056/nejm198909073211004 · Cited by 1,040
Changes in Proinflammatory Cytokine Activity after Menopause
Pfeilschifter, J., Köditz, R., Pfohl, M., & Schatz, H. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0456 · Cited by 914 · cited 1×
“Several studies have shown higher IL-6 levels in postmenopausal compared with premenopausal women (79).”
BackgroundAndrogens Decrease Plasma Adiponectin, an Insulin-Sensitizing Adipocyte-Derived Protein
Nishizawa, H., Shimomura, I., Kishida, K., Maeda, N., Kuriyama, H., Nagaretani, H., Matsuda, M., Kondo, H., Furuyama, N., Kihara, S., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2734 · Cited by 837 · cited 1×
“However, the only study evaluating adiponectin in menopause revealed no difference in pre- and postmenopausal women (35).”
BackgroundThe Framingham Offspring Study
Allhoff, P., Laaser, U., & Heinrich, J. (1991) · Kompendium der Lipid-Studien · doi:10.1007/978-3-642-95642-3_25 · Cited by 831
Clustering of metabolic factors and coronary heart disease
Wilson, P. W. F., Kannel, W. B., Silbershatz, H., & D'Agostino, R. B. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.10.1104 · Cited by 712 · cited 1×
“The risk of CVD attributed to the metabolic syndrome appears to be especially high in women, and it is estimated that half of all cardiovascular events in women are related to the metabolic syndrome (15).”
BackgroundPradhan, A. D., Manson, J. E., Rossouw, J. E., Siscovick, D. S., Mouton, C. P., Rifai, N., Wallace, R. B., Jackson, R. D., Pettinger, M. B., & Ridker, P. M. (2002) · JAMA · doi:10.1001/jama.288.8.980 · Cited by 680 · cited 1×
“Recent data from the Women’s Health Initiative revealed that higher baseline CRP and IL-6 levels predicted cardiovascular outcomes in apparently healthy older women (78).”
MethodVisceral Obesity in Men: Associations With Glucose Tolerance, Plasma Insulin, and Lipoprotein Levels
Pouliot, M.-C., Després, J.-P., Nadeau, A., Moorjani, S., Prud'Homme, D., Lupien, P. J., Tremblay, A., & Bouchard, C. (1992) · Diabetes · doi:10.2337/diab.41.7.826 · Cited by 635 · cited 1×
“Abdominal obesity is closely associated with increased insulin resistance, compensatory hyperinsulinemia, and increased risk of type 2 diabetes, independent of an individual’s total body fat content (62).”
BackgroundEndogenous tissue-type plasminogen activator and risk of myocardial infarction
Ridker, P. M., Vaughan, D. E., Manson, J., Hennekens, C., & Stampfer, M. (1993) · The Lancet · doi:10.1016/0140-6736(93)90998-v · Cited by 582 · cited 1×
“High PAI-1 activity is associated with high plasma levels of tPA antigen (which represents t-PA/PAI-1 complexes), which has been found to be independently associated with CVD in both men and women (70).”
BackgroundAbdominal obesity as important component of insulin-resistance syndrome.
Després, J. (1993) · PubMed · Cited by 567
Juhan-Vague, I., Pyke, S. D. M., Alessi, M. C., Jespersen, J., Haverkate, F., & Thompson, S. G. (1996) · Circulation · doi:10.1161/01.cir.94.9.2057 · Cited by 552
Weight Loss Reduces C-Reactive Protein Levels in Obese Postmenopausal Women
Tchernof, A., Nolan, A., Sites, C. K., Ades, P. A., & Poehlman, E. T. (2002) · Circulation · doi:10.1161/hc0502.103331 · Cited by 541 · cited 1×
“Like PAI-1, CRP is positively associated with total body fat mass and abdominal fat, and weight loss in postmenopausal women has been shown to reduce CRP levels by 32% (75).”
BackgroundInfluence of age and menopause on serum lipids and lipoproteins in healthy women
Stevenson, J. C., Crook, D., & Godsland, I. F. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90225-j · Cited by 537 · cited 1×
“the more antiatherogenic HDL2 levels decrease (by 25%), whereas HDL3 levels increase (26, 30, 40, 53).”
BackgroundRegional obesity and risk of cardiovascular disease; the Framingham study
Kannel, W. B., Adrienne Cupples, L., Ramaswami, R., Stokes, J., Kreger, B. E., & Higgins, M. (1991) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(91)90265-b · Cited by 535 · cited 1×
“The accumulation of fat in a central distribution (intraabdominal) has emerged as a cardiovascular risk factor independent of overall obesity (20).”
BackgroundHormonal changes in the menopause transition
Burger, H. G. (2002) · Recent Progress in Hormone Research · doi:10.1210/rp.57.1.257 · Cited by 530 · cited 2×
“Menstrual history is the most reliable indicator of the postmenopausal state, as specific hormonal measures, such as estradiol (E2) and FSH levels both vary widely in the perimenopause during an individual menstrual cycle (2).”
BackgroundLow density lipoprotein particle size and coronary artery disease.
Campos, H., Genest, J. J., Blijlevens, E., McNamara, J. R., Jenner, J. L., Ordovas, J. M., Wilson, P. W., & Schaefer, E. J. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.2.187 · Cited by 509 · cited 1×
“A preponderance of small, dense LDL is associated with an increased risk of myocardial infarction (45) as well as the severity of CVD (46).”
BackgroundEffect of menopausal status on body composition and abdominal fat distribution
Toth, M., Tchernof, A., Sites, C., & Poehlman, E. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801118 · Cited by 503 · cited 1×
“Abdominal fat, measured by CT scan, has also been shown to increase with menopause in both cross-sectional (29) and prospective studies (30).”
BackgroundAging, body composition, and lifestyle: the Fels Longitudinal Study
Guo, S. S., Zeller, C., Chumlea, W. C., & Siervogel, R. M. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/70.3.405 · Cited by 408 · cited 1×
“55 kg ( 1 lb)/yr, there does not appear to be an independent effect of menopause on body weight (25, 26).”
BackgroundRisk factors that attenuate the female coronary disease advantage
Kannel, W. B. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430010063008 · Cited by 381
Shlipak, M. G. (2000) · JAMA · doi:10.1001/jama.283.14.1845 · Cited by 371
Landin, K., Stigendal, L., Eriksson, E., Krotkiewski, M., Risberg, B., Tengborn, L., & Smith, U. (1990) · Metabolism · doi:10.1016/0026-0495(90)90164-8 · Cited by 342 · cited 1×
“PAI-1 is produced by liver and adipose tissue, particularly visceral adipose tissue (71), and is thought to be a marker of insulin resistance.”
BackgroundJenner, J. L., Ordovas, J. M., Lamon-Fava, S., Schaefer, M. M., Wilson, P. W., Castelli, W. P., & Schaefer, E. J. (1993) · Circulation · doi:10.1161/01.cir.87.4.1135 · Cited by 338
Influence of menopause on serum lipids and lipoproteins
Jensen, J., Nilas, L., & Christiansen, C. (1990) · Maturitas · doi:10.1016/0378-5122(90)90012-u · Cited by 335 · cited 2×
“menopause (23, 38, 41, 51), whereas others reveal no changes”
BackgroundJanowitz, W. R., Agatston, A. S., Kaplan, G., & Viamonte, M. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90668-3 · Cited by 309 · cited 1×
“Similarly, coronary artery calcium deposits in women, measured by computed tomography (CT), was half that in men until the age of 60 yr, when the difference decreased (8).”
BackgroundGebara, O. C. E., Mittleman, M. A., Sutherland, P., Lipinska, I., Matheney, T., Xu, P., Welty, F. K., Wilson, P. W. F., Levy, D., Muller, J. E., et al. (1995) · Circulation · doi:10.1161/01.cir.91.7.1952 · Cited by 298 · cited 1×
“Age-matched men have higher levels of tPA antigen than premenopausal women (73).”
BackgroundLoss of abdominal fat and metabolic response to exercise training in obese women
Despres, J. P., Pouliot, M. C., Moorjani, S., Nadeau, A., Tremblay, A., Lupien, P. J., Theriault, G., & Bouchard, C. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.261.2.e159 · Cited by 292 · cited 1×
“loss than subcutaneous adipocytes (80).”
Increased risk of atherosclerosis in women after the menopause.
Witteman, J. C., Grobbee, D. E., Kok, F. J., Hofman, A., & Valkenburg, H. A. (1989) · BMJ · doi:10.1136/bmj.298.6674.642 · Cited by 275
Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis.
Austin, M. A., King, M., VRANIZAN, K. M., Newman, B. M., & Krauss, R. M. (1988) · PubMed Central · Cited by 256
CAMPOS, H., MCNAMARA, WILSON, P. W. F., ORDOVAS, J. M., & SCHAEFER, E. J. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-1-30 · Cited by 251 · cited 1×
“The prevalence of small, dense LDL is low in premenopausal women (10–13%), but increases to 30–49% in postmenopausal women (39, 43, 44) (Table 4).”
BackgroundSchrott, H. G. (1997) · JAMA · doi:10.1001/jama.1997.03540400031027 · Cited by 251 · cited 1×
“Baseline data from the Heart and Estrogen/Progestin Replacement Study revealed that more than 60% of women with proven CVD did not meet the National Cholesterol Education Program goals for LDL lowering (81).”
MethodThe role of hepatic lipase in lipoprotein metabolism and atherosclerosis
Santamarina-Fojo, S., Haudenschild, C., & Amar, M. (1998) · Current Opinion in Lipidology · doi:10.1097/00041433-199806000-00005 · Cited by 230
DeNino, W. F., Tchernof, A., Dionne, I. J., Toth, M. J., Ades, P. A., Sites, C. K., & Poehlman, E. T. (2001) · Diabetes Care · doi:10.2337/diacare.24.5.925 · Cited by 227 · cited 2×
“They found that reduced insulin sensitivity did not appear until women were older than 60 yr and had accumulated levels of visceral fat that approximated the levels seen in men, suggesting a possible threshold effect of abdominal fat on insulin resistance (67).”
BackgroundMatthews, K. A., Kuller, L. H., Sutton-Tyrrell, K., & Chang, Y.-F. (2001) · Stroke · doi:10.1161/01.str.32.5.1104 · Cited by 225 · cited 2×
“in LDL concentration appears to occur early in the transition from premenopause to postmenopause (42).”
BackgroundZamboni, M. M., Armellini, F., Milani, M. P., Marchi, M. D., Todesco, T., Robbi, R., Bergamo-Andreis, I. A., & Bosello, O. (1992) · PubMed · Cited by 204
EPIDEMIOLOGY OF THE METABOLIC SYNDROME
Meigs, J. B. (2002) · Cited by 202
Larsson, B., Bengtsson, C., Björntorp, P., Lapidus, L., Sjöstrom, L., Svardsudd, K., Tlbblin, G., Wedel, H., Welin, L., & Wilhelmsen, L. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116280 · Cited by 198 · cited 1×
“Accumulation of excess abdominal fat with transition through the menopause plays a central role in connecting the metabolic syndrome with the metabolic alterations of menopause and may account, in part, for the temporal separation in CVD risk between men and women (82).”
BackgroundWALTON, C., GODSLAND, I. F., PROUDLER, A. J., WYNN, V., & STEVENSON, J. C. (1993) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1993.tb00792.x · Cited by 197
Sutton-Tyrrell, K., Lassila, H. C., Meilahn, E., Bunker, C., Matthews, K. A., & Kuller, L. H. (1998) · Stroke · doi:10.1161/01.str.29.6.1116 · Cited by 181
Longitudinal Study of Risk Factors for Coronary Heart Disease Across the Menopausal Transition
Do, K.-A., Green, A., Guthrie, J. R., Dudley, E. C., Burger, H. G., & Dennerstein, L. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010246 · Cited by 172 · cited 1×
“menopause (23, 38, 41, 51), whereas others reveal no changes”
BackgroundLamarche, B., Moorjani, S., Cantin, B., Dagenais, G. R., Lupien, P. J., & Després, J.-P. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.6.1098 · Cited by 170 · cited 1×
“dependent on variations in HDL2 levels (54).”
Sites, C. K., Toth, M. J., Cushman, M., L’Hommedieu, G. D., Tchernof, A., Tracy, R. P., & Poehlman, E. T. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02934-x · Cited by 164 · cited 1×
“(76) recently found no differences in CRP between premenopausal (mean age, 47 yr) and early postmenopausal (mean age, 51 yr) women; however these healthy women may have had relatively few differences in atherosclerotic plaque burden.”
BackgroundReproductive history in relation to relative weight and fat distribution.
Björkelund, C., Lissner, L., Andersson, S., Lapidus, L., & Bengtsson, C. (1996) · PubMed · Cited by 153
Epidemiology of the metabolic syndrome, 2002.
Meigs, J. B. (2002) · PubMed · Cited by 151
Effects of gender and menopausal status on plasma lipoprotein subspecies and particle sizes
Li, Z., McNamara, J. R., Fruchart, J. C., Luc, G., Bard, J. M., Ordovas, J. M., Wilson, P. W., & Schaefer, E. J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37553-2 · Cited by 148
Lindheim, S. R., Buchanan, T. A., Duffy, D. M., Vijod, M. A., Kojima, T., Stanczyk, F. Z., & Løbo, R. A. (1994) · Journal of the Society for Gynecologic Investigation · doi:10.1177/107155769400100210 · Cited by 142
Differences in Adipose Tissue Metabolism between Postmenopausal and Perimenopausal Women
Ferrara, C. M., Lynch, N. A., Nicklas, B. J., Ryan, A. S., & Berman, D. M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-012034 · Cited by 134 · cited 1×
“Regional differences in adipose tissue lipoprotein lipase activity in postmenopause may account for the menopausal changes in fat accumulation, but results to date are conflicting (33, 34).”
BackgroundCrawford, S. L., Casey, V. A., Avis, N. E., & McKinlay, S. M. (2000) · Menopause · doi:10.1097/00042192-200007020-00005 · Cited by 126 · cited 1×
“sociated with weight gain, most studies do not reveal increases in BMI independent of normal aging (23, 24).”
BackgroundDallongeville, J., Marecaux, N., Isorez, D., Zylbergberg, G., Fruchart, J. C., & Amouyel, P. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)05599-r · Cited by 125 · cited 2×
“Until recently, hormone replacement therapy (HRT) was an option for treatment of the postmenopausal metabolic syndrome, because it improved many of the metabolic abnormalities (63).”
BackgroundChanges in LDL Density across the Menopausal Transition
Carr, M. C., Kim, K. H., Zambon, A., Mitchell, E. S., Woods, N. F., Casazza, C. P., Purnell, J. Q., Hokanson, J. E., Brunzell, J. D., & Schwartz, R. S. (2000) · Journal of Investigative Medicine · doi:10.1177/108155890004800405 · Cited by 118 · cited 1×
“The prevalence of small, dense LDL is low in premenopausal women (10–13%), but increases to 30–49% in postmenopausal women (39, 43, 44) (Table 4).”
BackgroundSelf-citationMackey, R. H., Kuller, L. H., Sutton‐Tyrrell, K., Evans, R. G., Holubkov, R., & Matthews, K. A. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02636-x · Cited by 116 · cited 1×
“(47) recently showed by electron beam CT that postmenopausal women with high coronary calcium scores had smaller LDL particle size, higher LDL levels, and fewer large HDL2 particles than postmenopausal women with low coronary calcium scores.”
BackgroundGenetics and the metabolic syndrome.
Bouchard, C. (1995) · PubMed · Cited by 95
Coronary artery disease - is menopause a risk factor?
Gohlke-Bärwolf, C. (2000) · Basic Research in Cardiology · doi:10.1007/s003950070014 · Cited by 94 · cited 2×
“Premature, surgically induced menopause has been shown to increase the risk for CVD (4).”
BackgroundConcordance for Dyslipidemic Hypertension in Male Twins
Selby, J. V. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03460160057029 · Cited by 91
Lindquist, O. (1982) · Preventive Medicine · doi:10.1016/0091-7435(82)90015-9 · Cited by 90 · cited 3×
“Data are from Lindquist (50), Matthews et al. (41), Jensen et al. (38), Poehlman et al. (23), and Do et al. (51).”
BackgroundInfluentialCoronary Heart Disease Risk Factors in Relation to the Menopause
Razay, G., Heaton, K. W., & Bolton, C. (1992) · QJM · doi:10.1093/oxfordjournals.qjmed.a068726 · Cited by 87 · cited 2×
“Several groups have shown increased fasting insulin (22, 48) and increased fasting glucose levels (37, 63) in postmenopausal compared with premenopausal women, which would imply worsened insulin resistance with the menopause.”
BackgroundComparison of VO2max and disease risk factors between perimenopausal and postmenopausal women
Lynch, N. A., Ryan, A. S., Berman, D. M., Sorkin, J. D., & Nicklas, B. J. (2002) · Menopause The Journal of The North American Menopause Society · doi:10.1097/00042192-200211000-00012 · Cited by 83 · cited 2×
“Lynch et al. ( 37 ) recently reported lower maximal oxygen consumption (VO2 max) in sedentary postmenopausal (VO2 max) women compared with sedentary age-matched premenopausal women and found an inverse relationship between visceral adiposity and maximal oxygen consumption.”
BackgroundToth, M. J., Sites, C. K., Eltabbakh, G. H., & Poehlman, E. T. (2000) · Diabetes Care · doi:10.2337/diacare.23.6.801 · Cited by 81 · cited 1×
“However, others have shown no differences in insulin sensitivity in postmenopausal compared with premenopausal women (65, 66).”
BackgroundThe Heart and Estrogen/progestin Replacement Study (HERS)
Speroff, L. (1998) · Maturitas · doi:10.1016/s0378-5122(98)00104-2 · Cited by 75
Berg, G. A., Siseles, N., lez, A. I. G., Ortiz, O. C., Tempone, A., & Wikinski, R. (2001) · Menopause The Journal of The North American Menopause Society · doi:10.1097/00042192-200101000-00009 · Cited by 70
Deterioration of the Metabolic Risk Profile in Women
Pascot, A., Després, J., Lemieux, I., Alméras, N., Bergeron, J., Nadeau, A., Prud’homme, D., Tremblay, A., & Lemieux, S. (2001) · Diabetes Care · doi:10.2337/diacare.24.5.902 · Cited by 66 · cited 1×
“(32) matched women for abdominal fat (by CT scan) and menopausal status, the differences initially found in very low density lipoprotein (VLDL), LDL, HDL, large buoyant HDL2 particles, LDL particle size, fasting glucose, C peptide, and blood pressure were eliminated, implying that the differences in visceral fat and m…”
Background(1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400060019005 · Cited by 64
Lipoprotein(a) and other lipids after oophorectomy and estrogen replacement therapy
Bruschi, F., Meschìa, M., Soma, M. R., PEROTTI, D., Paoletti, R., & GIORGIOCROSIGNANI, P. (1996) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(96)00349-3 · Cited by 58
Variation of postheparin plasma hepatic lipase by menstrual cycle
Tikkanen, M. J., Kuusi, T., Nikkilä, E. A., & Stenman, U. (1986) · Metabolism · doi:10.1016/0026-0495(86)90107-1 · Cited by 58
Impaired fasting glycaemia in middle-aged women: a prospective study
Guthrie, Jr., Ball, M., Dudley, E., Garamszegi, C., Wahlqvist, M., Dennerstein, L., & Burger, H. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801569 · Cited by 45 · cited 2×
“There was no difference in menopausal status between the two groups; this implies that weight gain had a stronger influence on the development of impaired fasting glucose than menopause itself (68).”
BackgroundPassage of the menopause is followed by haemostatic changes
Lindoff, C., Petersson, F., Lecander, I., Martinsson, G., & Åstedt, B. (1993) · Maturitas · doi:10.1016/0378-5122(93)90119-3 · Cited by 34 · cited 1×
“Postmenopausal women have higher levels of PAI-1 and tPA antigen than premenopausal women (72).”
BackgroundMauriège, P., Imbeault, P., Prudhomme, D. J., Tremblay, A., Nadeau, A., & Després, J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6687 · Cited by 33 · cited 1×
“Regional differences in adipose tissue lipoprotein lipase activity in postmenopause may account for the menopausal changes in fat accumulation, but results to date are conflicting (33, 34).”
BackgroundLewis-Barned, N. J., Sutherland, W. H. F., Walker, R. J., Walker, H. L., de Jong, S. A., Edwards, E. A., & Markham, V. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6022 · Cited by 19
Cited by
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
“Furthermore, it is unclear whether the menopause-related increases in insulin resistance and dyslipidemia are the result of estrogen deficiency directly or occur secondary to increases in abdominal adiposity (459).”
BackgroundThe role of estrogens in control of energy balance and glucose homeostasis
Mauvais-Jarvis, F., Clegg, D. J., & Hevener, A. L. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1055 · Cited by 1,329
“After menopause or OVX, a precipitous decline in insulin sensitivity parallels an increase in fat mass and elevations in circulating inflammatory markers, low-density lipoprotein (LDL), triglycerides, and fatty acids (6, 169, 170).”
BackgroundGrundy, S. M. (2011) · Atlas of Atherosclerosis and Metabolic Syndrome · doi:10.1007/978-1-4419-5839-6_1 · Cited by 1,223
Muka, T., Oliver-Williams, C., Kunutsor, S., Laven, J. S. E., Fauser, B. C. J. M., Chowdhury, R., Kavousi, M., & Franco, O. H. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.2415 · Cited by 826
Salpeter, S. R., Walsh, J. M. E., Ormiston, T. M., Greyber, E., Buckley, N. S., & Salpeter, E. E. (2006) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00545.x · Cited by 640
Metadata
- Authors
- Carr, M. C.
- Affiliations
- University of Washington (US)
- Corresponding author
- Carr, Molly C.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-06
- Volume
- 88
- Issue
- 6
- Pages
- 2404-2411
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2123609879
- Cited by
- 1,449
- References
- 84
- Citations by year
- 2026: 54 · 2025: 64 · 2024: 55 · 2023: 67 · 2022: 69 · 2021: 69 · 2020: 65 · 2019: 67 · 2018: 86 · 2017: 61 · 2016: 97 · 2015: 91 · 2014: 79 · 2013: 84 · 2012: 86
- FWCI
- 18.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- metabolic syndrome, menopause, estrogen deficiency, ovarian failure, abdominal obesity, insulin resistance, dyslipidemia, cardiovascular risk, postmenopausal women, atherogenic lipid profile, small dense LDL, glucose metabolism
- MeSH terms
- Body Composition, Cardiovascular Diseases, Female, Humans, Menopause, Risk Factors, Prevalence, Metabolic Syndrome, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.